KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Brunswick (BC) Cash & Equivalents (2016 - 2025)

Brunswick (BC) has disclosed Cash & Equivalents for 16 consecutive years, with $256.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 10.43% to $256.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $256.8 million, a 10.43% decrease, with the full-year FY2025 number at $256.8 million, down 10.43% from a year prior.
  • Cash & Equivalents was $256.8 million for Q4 2025 at Brunswick, down from $297.7 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.5 billion in Q4 2021 to a low of $11.1 million in Q4 2023.
  • A 5-year average of $444.7 million and a median of $422.6 million in 2022 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: surged 4781.97% in 2022, then tumbled 98.14% in 2023.
  • Brunswick's Cash & Equivalents stood at $12.2 million in 2021, then soared by 4781.97% to $595.6 million in 2022, then crashed by 98.14% to $11.1 million in 2023, then soared by 2482.88% to $286.7 million in 2024, then fell by 10.43% to $256.8 million in 2025.
  • Per Business Quant, the three most recent readings for BC's Cash & Equivalents are $256.8 million (Q4 2025), $297.7 million (Q3 2025), and $315.7 million (Q2 2025).